Edmond de Rothschild Holding’s Juno Therapeutics, Inc. JUNO Stock Holding History

Edmond de Rothschild Holding’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,475	Closed	-$55K	–	869
2017 Q1	$55K	Sell	2,475 -1,600	-39%	-$34.3K	﹤0.01%	640
2016 Q4	$77K	Buy	4,075 +825	+25%	+$20.2K	﹤0.01%	601
2016 Q3	$98K	Buy	3,250 +2,750	+550%	+$85.6K	﹤0.01%	593
2016 Q2	$19K	Sell	500 -500	-50%	-$20.8K	﹤0.01%	736
2016 Q1	$38K	Sell	1,000 -425	-30%	-$14.8K	﹤0.01%	668
2015 Q4	$63K	Buy	1,425 +800	+128%	+$39.7K	﹤0.01%	601
2015 Q3	$25K	Buy	+625	New	+$27.4K	﹤0.01%	692

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edmond de Rothschild Holding's JUNO Position: Q2 2017 in Review

Edmond de Rothschild Holding sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2017, closing a stake of 2,475 shares — an estimated $55K sold.

Edmond de Rothschild Holding first reported a position in JUNO in Q3 2015 and held it in 7 quarters. The position peaked at $98K in Q3 2016. 173 funds tracked by Wall St. Rank hold JUNO as of Q2 2017.

Edmond de Rothschild Holding reported no remaining Juno Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
Edmond de Rothschild Holding sold 2,475 Juno Therapeutics, Inc. shares in Q2 2017, an estimated $55K.
Edmond de Rothschild Holding first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 7 quarters.
Edmond de Rothschild Holding's Juno Therapeutics, Inc. position peaked at $98K in Q3 2016.
173 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2017.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2017, filed 10 Aug 2017.